Fostering Efficiency and Quality in Pharma Manufacturing Through AspenTech Pharma Suite

KB at your finger tips

This is one stop global knowledge base where you can learn about all the products, solutions and support features.

Products-AspenTech Pharma Suite

Fostering Efficiency and Quality in Pharma Manufacturing Through AspenTech Pharma Suite

Enhancing Pharma Manufacturing Efficiencies

Ferring Pharmaceuticals, a prominent biopharmaceutical company, sought ways to expedite commercialization, optimize production costs, and reduce supply lead times while upholding product quality in line with their digitalization objectives. To address these challenges, Ferring Pharmaceuticals implemented AspenTech's Advanced Process Analytical Technology (PAT) solution, leveraging Aspen Unscrambler™ and Aspen Process Pulse™.

Ensuring Product Quality with PAT-enabled closed-loop control

By harnessing the power of PAT-enabled closed-loop control, Ferring Pharmaceuticals guarantees on-spec product quality in their continuous manufacturing processes. This approach minimizes variability and ensures consistent quality output, bolstering Ferring's reputation for delivering high-quality pharmaceutical products.

Reducing Footprint and Costs with Continuous Manufacturing

A significant advantage of continuous manufacturing over batch processes is the smaller footprint it requires, leading to substantial savings in expensive clean room space. This streamlined production method not only reduces operational costs but also enhances overall efficiency by eliminating the need for extensive equipment scaleup, thereby optimizing production agility.

Real-time Release Testing for Improved Efficiency

The integration of real-time release testing within Ferring Pharmaceuticals' manufacturing processes has revolutionized quality control measures. By conducting tests in real-time rather than relying on offline laboratory testing, Ferring reduces delays and costs associated with traditional testing methods, facilitating faster product release and time-to-market.

Driving Innovation and Adaptability in Pharma Manufacturing

Through the adoption of AspenTech Pharma Suite, Ferring Pharmaceuticals exemplifies a commitment to innovation and adaptability in pharmaceutical manufacturing. By leveraging cutting-edge technologies like PAT and closed-loop control, Ferring not only enhances production efficiencies but also paves the way for future advancements in the industry.

Stay Ahead in Today’s Competitive Market!
Unlock your company’s full potential with a Virtual Delivery Center (VDC). Gain specialized expertise, drive seamless operations, and scale effortlessly for long-term success.

Book A Meeting To Setup A VDC

AspenTech Pharma Suite: Revolutionizing Carbon Capture, Utilization, and Storage Innovations

Accelerate Innovation for Carbon Capture, Utilization and Storage (CCUS)

AspenTech's Pharma Suite offers cutting-edge digital solutions to accelerate innovation in Carbon Capture, Utilization, and Storage (CCUS). This suite is designed to improve economics, reduce risks, and expedite the scaling and commercialization of CO2 capture technologies. By leveraging process simulation, risk analysis, and subsurface modeling tools, AspenTech enables organizations to address challenges in driving low-risk CCUS solutions at scale. This results in a 5-20% reduction in CAPEX, a 15-30% decrease in OPEX, and a 20% project time reduction. Additionally, these solutions support permit applications, decrease permitting time by 50%, aid in selecting storage locations, demonstrate permanent geological storage, and scale up CO2 to chemicals utilization technologies.

Read article

Enhancing Energy Management with AspenTech Pharma Suite

Introduction to AspenTech OSI Energy Management System™

AspenTech OSI Energy Management System™ is a transformative solution suite designed to balance the transport of power on the transmission grid through reliable real-time operations while facilitating renewable energy integration. The system aims to increase resilience and reliability while accelerating the clean energy transition by offering a scalable and flexible platform with a modular architecture that supports system growth and advanced renewable management. With a feature-rich solution and a global install base, this system plays a crucial role in balancing country-level bulk electric for enhanced efficiency.

Read article

Optimizing Reliability and Maintenance Programs with AspenTech Pharma Suite

Empower Your Reliability and Maintenance Teams

AspenTech Pharma Suite offers a solution that optimizes maintenance programs for improved production and reduced overall costs by predicting and minimizing the impact of equipment downtime. This allows organizations to reduce maintenance costs by 20-30% per year and increase throughput by 1-5%. By leveraging the power of AI-driven prescriptive maintenance, businesses can enhance the precision of failure detection, extend the lead time for anticipating asset downtime events, and ultimately reduce maintenance expenses. Industrial companies worldwide are successfully implementing this scalable, user-friendly solution to drive best-in-class reliability.

Read article

Optimizing Heat Exchangers with Aspen Exchanger Design & Rating

Comprehensive Heat Exchanger Design Solutions

Aspen Exchanger Design & Rating (EDR)™ offers a cutting-edge solution to optimize both CAPEX and OPEX by integrating heat exchangers into the larger process model with rigorous HX models and seamless data flow. This software provides a comprehensive set of rigorous HX models, allowing for accurate design and rating of heat exchangers across different disciplines. By utilizing Aspen EDR, companies can achieve the most optimal designs that balance performance and economics effectively.

Read article

Transforming Industries Towards Sustainability with AspenTech Pharma Suite

The Importance of Decarbonization

Asset-intensive industries are significant contributors to global resources, economic growth, and employment opportunities. However, these industries are also responsible for a substantial portion of the world's greenhouse gas emissions. To address this issue and meet the ambitious emissions reduction targets set by the Paris Agreement, industrial processes must undergo decarbonization. According to a McKinsey study, industrial activity alone contributes to 28% of total global GHG emissions, highlighting the urgent need for sustainable solutions.

Read article

Welcome to Knowledge Base!

KB at your finger tips

Products-AspenTech Pharma Suite